HMBD-004B

N/A

Report date: 2023/03/05 19:04:11

Base Information

Drug NameHMBD-004B

Drug Alias NameHMBD-004B

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Cluster of differentiation 47Anti-Myeloid cell surface antigen CD33

TargetsCluster of differentiation 47Myeloid cell surface antigen CD33

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHummingbird Bioscience

China Registration ClassN/A

Develop Information

Active CompaniesHummingbird Bioscience

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A